New York City-based Memorial Sloan Kettering Cancer Center plans to implement Abridge’s AI platform across its system in 2025 and 2026.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Memorial Sloan Kettering expands Abridge rollout
